Filtres: First Letter Of Title és G [Clear All Filters]
Gene expression differences between colon and rectum tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011;17(23):7303-12.
Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis. British journal of cancer. 2009;101(8):1469-80.
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(1):17-24.
Gene set-based analysis of polymorphisms: finding pathways or biological processes associated to traits in genome-wide association studies. Nucleic acids research. 2009;37(Web Server issue):W340-4.
Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. BMC genomics. 2008;9:12.
Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis. 2012;27(2):169-76.
Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. European journal of human genetics : EJHG. 2012.
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer research. 2008;68(24):10178-86.
Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer prevention research (Philadelphia, Pa.). 2010;3(5):597-603.
Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer biology & therapy. 2007;6(7):1143-7.
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). International journal of oncology. 2012;40(3):625-38.
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature genetics. 2008;40(5):631-7.
Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International journal of oncology. 2007;30(5):1099-107.
A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer. British journal of cancer. 2011;105(1):53-7.